Soleno Therapeutics Inc [SLNO] stock is trading at $84.17, up 3.38%. An important factor to consider is whether the stock is rising or falling in short-term value. The SLNO shares have gain 7.70% over the last week, with a monthly amount glided 13.91%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Soleno Therapeutics Inc [NASDAQ: SLNO] stock has seen the most recent analyst activity on June 23, 2025, when TD Cowen initiated its Buy rating and assigned the stock a price target of $110. On December 02, 2024, Stifel reiterated its Buy rating but maintained its price target of $74 on the stock. Robert W. Baird reiterated its Outperform rating but stick to its price target of $72 on December 02, 2024. H.C. Wainwright initiated its recommendation with a Buy and recommended $70 as its price target on September 03, 2024. Robert W. Baird started tracking with a Outperform rating for this stock on May 10, 2024, and assigned it a price target of $72. In a note dated February 05, 2024, Piper Sandler initiated an Overweight rating and provided a target price of $93 on this stock.
Soleno Therapeutics Inc [SLNO] stock has fluctuated between $36.93 and $81.60 over the past year. Currently, Wall Street analysts expect the stock to reach $96 within the next 12 months. Soleno Therapeutics Inc [NASDAQ: SLNO] shares were valued at $84.17 at the most recent close of the market. An investor can expect a potential return of 14.05% based on the average SLNO price forecast.
Analyzing the SLNO fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.62, Equity is -0.78 and Total Capital is -0.54. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 81.44 points at the first support level, and at 78.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 86.13, and for the 2nd resistance point, it is at 88.09.
Ratios To Look Out For
For context, Soleno Therapeutics Inc’s Current Ratio is 19.64. On the other hand, the Quick Ratio is 19.64, and the Cash Ratio is 5.17.
Transactions by insiders
Recent insider trading involved PATRICIA HIRANO, Officer, that happened on Jun 24 ’25 when 266.0 shares were purchased., Hirano Patricia C completed a deal on Apr 01 ’25 to sell 3782.0 shares. Meanwhile, Officer PATRICIA HIRANO bought 3782.0 shares on Apr 01 ’25.
